Premium
Letter: vedolizumab for the management of inflammatory bowel disease in patients after liver transplantation for primary sclerosing cholangitis
Author(s) -
Hartery K.,
O'Reilly S.,
Houlihan D.,
Doherty G.,
Mulcahy H.,
Cullen G.,
Sheridan J.
Publication year - 2017
Publication title -
alimentary pharmacology and therapeutics
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 3.308
H-Index - 177
eISSN - 1365-2036
pISSN - 0269-2813
DOI - 10.1111/apt.13861
Subject(s) - vedolizumab , medicine , primary sclerosing cholangitis , liver transplantation , inflammatory bowel disease , gastroenterology , ulcerative colitis , transplantation , disease
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom